Related references
Note: Only part of the references are listed.The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes
Hong Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Nathalie Dhomen et al.
CANCER CELL (2009)
Raf-1 Addiction in Ras-Induced Skin Carcinogenesis
Karin Ehrenreiter et al.
CANCER CELL (2009)
Sprouty2 Association with B-Raf Is Regulated by Phosphorylation and Kinase Conformation
Suzanne C. Brady et al.
CANCER RESEARCH (2009)
Sorafenib Inhibits Non-Small Cell Lung Cancer Cell Growth by Targeting B-RAF in KRAS Wild-Type Cells and C-RAF in KRAS Mutant Cells
Ken Takezawa et al.
CANCER RESEARCH (2009)
Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
Klaus P. Hoeflich et al.
CANCER RESEARCH (2009)
C-Raf Is Associated with Disease Progression and Cell Proliferation in a Subset of Melanomas
Lucia B. Jilaveanu et al.
CLINICAL CANCER RESEARCH (2009)
The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence
Karl Agger et al.
GENES & DEVELOPMENT (2009)
Identification of Novel in Vivo Phosphorylation Sites of the Human Proapoptotic Protein BAD PORE-FORMING ACTIVITY OF BAD IS REGULATED BY PHOSPHORYLATION
Lisa Polzien et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
From autoinhibition to inhibition in trans: the Raf-1 regulatory domain inhibits Rok-α kinase activity
Theodora Niault et al.
JOURNAL OF CELL BIOLOGY (2009)
Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma
Essa Y. Baitei et al.
JOURNAL OF PATHOLOGY (2009)
Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
William M. Old et al.
MOLECULAR CELL (2009)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
C-Raf Inhibits MAPK Activation and Transformation by B-RafV600E
Florian A. Karreth et al.
MOLECULAR CELL (2009)
Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations
A. Zebisch et al.
LEUKEMIA (2009)
A dimerization-dependent mechanism drives RAF catalytic activation
Thanashan Rajakulendran et al.
NATURE (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
NF-κB: A Key Player in Lung Cancer
[Anonymous]
CELL (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal
Federica Catalanotti et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
K. S. M. Smalley et al.
ONCOGENE (2009)
Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells
G. M. Argast et al.
ONCOGENE (2009)
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
D. T. W. Jones et al.
ONCOGENE (2009)
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
V. K. Goel et al.
ONCOGENE (2009)
V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
Christine A. Pratilas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Etienne Meylan et al.
NATURE (2009)
A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice
Rebecca Kinkade et al.
CANCER RESEARCH (2008)
Akt and mutant V600EB-Raf cooperate to promote early melanoma development
Mitchefl Cheung et al.
CANCER RESEARCH (2008)
Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma
Clara Montagut et al.
CANCER RESEARCH (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target
Lingchun Zeng et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development
Gergana Galabova-Kovacs et al.
JOURNAL OF CELL BIOLOGY (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
B-RAF regulation of Rnd3 participates in actin cytoskeletal and focal adhesion organization
R. Matthew Klein et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes
Berta Casar et al.
MOLECULAR CELL (2008)
CRAF autophosphorylation of serine 621 is required to prevent its proteasome-mediated degradation
Catherine Noble et al.
MOLECULAR CELL (2008)
B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic β-cell carcinogenesis
I. Sobczak et al.
ONCOGENE (2008)
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
D. Zhuang et al.
ONCOGENE (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Constitutive activation of Raf-1 induces glioma formation in mice
Yelena Lyustikman et al.
NEOPLASIA (2008)
Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels
Renaud Lefloch et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
Plasma membrane nanoswitches generate high-fidelity Ras signal transduction
Tianhai Tian et al.
NATURE CELL BIOLOGY (2007)
Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-Driven murine lung cancer
Fatih Ceteci et al.
CANCER CELL (2007)
Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation
Shile Liang et al.
CANCER RESEARCH (2007)
Binding of Ras to phosphoinositide 3-kinase p110α is required for Ras-driven tumorigenesis in mice
Surbhi Gupta et al.
CELL (2007)
Mutant V600E BRAF increases hypoxia inducible factor-1α expression in melanoma
Suresh M. Kumar et al.
CANCER RESEARCH (2007)
Chemoresistance of endothelial cells induced by basic fibroblast growth factor depends on Raf-1-mediated inhibition of the proapoptotic kinase, ASK1
Alireza S. Alavi et al.
CANCER RESEARCH (2007)
Raf 1 represses expression of the tight junction protein occludin via activation of the zinc-finger transcription factor Slug
Z. Wang et al.
ONCOGENE (2007)
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors
David Dankort et al.
GENES & DEVELOPMENT (2007)
Differential regulation of B-Raf isoforms by phosphorylation and autoinhibitory mechanisms
Isabelle Hmitou et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885
Alastair J. King et al.
CANCER RESEARCH (2006)
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling
Nicolas Dumaz et al.
CANCER RESEARCH (2006)
Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5
Alex von Kriegsheim et al.
NATURE CELL BIOLOGY (2006)
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
V. C. Gray-Schopfer et al.
BRITISH JOURNAL OF CANCER (2006)
Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases
Arati Sharma et al.
CANCER RESEARCH (2006)
Nicotine induces cell proliferation by β-arrestin-mediated activation of Src and Rb-Raf-1 pathways
Piyalli Dasgupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
Hidetoshi Sumimoto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity
P Rodriguez-Viciana et al.
MOLECULAR CELL (2006)
Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells
A Calipel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia
A Zebisch et al.
CANCER RESEARCH (2006)
Regulation and role of Raf-1/B-Raf heterodimerization
LK Rushworth et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Essential role of B-Raf in ERK activation during extraembryonic development
G Galabova-Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
BRAF mutation predicts sensitivity to MEK inhibition
DB Solit et al.
NATURE (2006)
Oncogenic BRAF is required for tumor growth and maintenance in melanoma models
MP Hoeflich et al.
CANCER RESEARCH (2006)
Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance
Kian-Huat Lim et al.
CELL (2006)
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
Vikas K. Goel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization
MJ Garnett et al.
MOLECULAR CELL (2005)
Raf-1 sets the threshold of Fas sensitivity by modulating Rok-α signaling
D Piazzolla et al.
JOURNAL OF CELL BIOLOGY (2005)
Expression of endogenous oncogenic V600EB-raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts
K Mercer et al.
CANCER RESEARCH (2005)
Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance
KH Lim et al.
CANCER CELL (2005)
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
W Kolch
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF
V Emuss et al.
CANCER RESEARCH (2005)
Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells
R Götz et al.
NATURE NEUROSCIENCE (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
LS Collier et al.
NATURE (2005)
Mammalian sterile 20-like kinases in tumor suppression: An emerging pathway
EE O'Neill et al.
CANCER RESEARCH (2005)
p21-Activated kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association
SH Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Second nature: Biological functions of the raf-1 kinase
M Baccarini
FEBS LETTERS (2005)
Mutant V599EB-RAF regulates growth and vascular development of malignant melanoma tumors
A Sharma et al.
CANCER RESEARCH (2005)
Raf-1 regulates Rho signaling and cell migration
K Ehrenreiter et al.
JOURNAL OF CELL BIOLOGY (2005)
RaIGDS is required for tumor formation in a model of skin carcinoigenesis
A González-García et al.
CANCER CELL (2005)
Regulation of raf-1 by direct feedback phosphorylation
MK Dougherty et al.
MOLECULAR CELL (2005)
Timeline - The discovery of receptor tyrosine kinases: targets for cancer therapy
A Gschwind et al.
NATURE REVIEWS CANCER (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Rote of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1
E O'Neill et al.
SCIENCE (2004)
The transcriptional response to Raf activation is almost completely dependent on mitogen-activated protein kinase kinase activity and shows a major autocrine component
A Schulze et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Oncogenic Raf-1 regulates epithelial to mesenchymal transition via distinct signal transduction pathways in an immortalized mouse hepatic cell line
MD Lan et al.
CARCINOGENESIS (2004)
The RAF proteins take centre stage
C Wellbrock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
GA Repasky et al.
TRENDS IN CELL BIOLOGY (2004)
Use of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo:: CI-1040 strongly reduces growth and improves lung structure -: art. no. 24
BW Kramer et al.
BMC CANCER (2004)
Disruption of the Rb-Raf-1 interaction inhibits tumor growth and angiogenesis
P Dasgupta et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
O Yamaguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Protein phosphatase 2A positively regulates ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites
S Ory et al.
CURRENT BIOLOGY (2003)
Role of Raf in vascular protection from distinct apoptotic stimuli
A Alavi et al.
SCIENCE (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Dephosphorylation of Ser-259 regulates Raf-1 membrane association
M Kubicek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis:: dissection of Ras signaling pathways
E Janda et al.
JOURNAL OF CELL BIOLOGY (2002)
Regulation of Raf-1 activation and signalling by dephosphorylation
AS Dhillon et al.
EMBO JOURNAL (2002)
Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism
J Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
MEK kinase activity is not necessary for Raf-1 function
M Hüser et al.
EMBO JOURNAL (2001)
Analysis of the transcriptional program induced by Raf in epithelial cells
A Schulze et al.
GENES & DEVELOPMENT (2001)
P19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes
E Roper et al.
EMBO REPORTS (2001)
Raf induces TGFβ production while blocking its apoptotic but not invasive responses:: a mechanism leading to increased malignancy in epithelial cells
K Lehmann et al.
GENES & DEVELOPMENT (2000)
Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation
D Abraham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development
M Sibilia et al.
CELL (2000)
Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation
B Baumann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin
DX Li et al.
JOURNAL OF CELL BIOLOGY (2000)
Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes
CK Weber et al.
ONCOGENE (2000)
The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
M Le Gall et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
Share Paper
